文献速递产科母胎医学

肥胖女性早期妊娠期糖尿病筛查的随机对照试验

Early gestational diabetes screening in obese women: a randomized controlled trial.
PubMed 文献 · Am J Obstet Gynecol · 2020-01-09

该随机对照试验纳入962例BMI≥30 kg/m2的肥胖孕妇,比较14-20周早期筛查与24-28周常规筛查对围产结局的影响。早期筛查组妊娠期糖尿病诊断率15.0%,常规筛查组12.1%,但主要复合结局发生率无显著差异(56.9% vs 50.8%,P=.07)。结论认为早期筛查未降低肥胖女性的复合围产结局。

要点

  • 肥胖孕妇早期筛查妊娠期糖尿病未改善围产结局。
  • 早期筛查组诊断率15.0%,常规筛查组12.1%。
  • 主要复合结局两组无统计学差异(P=.07)。

核心结论

  • 在肥胖女性中,早期筛查妊娠期糖尿病未能降低复合围产结局的发生率。

研究设计与样本

  • 随机对照试验,在美国2个三级医疗中心进行,纳入962例BMI≥30 kg/m2的肥胖孕妇,随机分入早期筛查组(14-20周)或常规筛查组(24-28周)。

主要发现

  • 早期筛查组妊娠期糖尿病诊断率为15.0%(95%CI 11.9-18.6%),其中6.3%(95%CI 4.3-8.9%)在<20周诊断,8.7%(95%CI 6.3-11.7%)在>24周诊断;常规筛查组诊断率为12.1%(95%CI 9.3-15.4%)。
  • 主要复合结局发生率早期筛查组为56.9%,常规筛查组为50.8%,差异无统计学意义(P=.07;相对风险1.12;95%CI 0.99-1.26)。

关键数值与推荐

  • 筛查采用50g、1小时葡萄糖挑战试验,若初始筛查≥135 mg/dL则行100g、3小时葡萄糖耐量试验。
  • 妊娠期糖尿病诊断采用Carpenter-Coustan标准。
  • 主要复合结局包括巨大儿(>4000g)、初次剖宫产、妊娠期高血压疾病、肩难产、新生儿高胆红素血症和新生儿低血糖(出生后48小时内评估)。

临床怎么用

  • 对于肥胖孕妇,早期筛查妊娠期糖尿病虽可更早诊断部分病例,但并未显著改善围产结局,临床决策需权衡早期筛查的获益与资源投入。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although in 2013 the American College of Obstetricians and Gynecologists recommended early screening for gestational diabetes in obese women, no studies demonstrate an improvement in perinatal outcomes with this strategy. OBJECTIVE: We sought to determine whether early screening for gestational diabetes improves perinatal outcomes in obese women. MATERIALS AND METHODS: Randomized controlled trial comparing early gestational diabetes screening (14-20 weeks) to routine screening (24-28 weeks) in obese women (body mass index ≥30 kg/m2) at 2 tertiary care centers in the United States. Screening was performed using a 50-g, 1-hour glucose challenge test followed by a 100-g, 3-hour glucose tolerance test if the initial screen was ≥135 mg/dL. Gestational diabetes was diagnosed using Carpenter-Coustan criteria. Women not diagnosed at 14 to 20 weeks were rescreened at 24 to 28 weeks. Exclusion criteria were pre-existing diabetes, major medical illness, bariatric surgery, and prior cesarean delivery. The primary outcome was a composite of macrosomia (>4000 g), primary cesarean delivery, hypertensive disease of pregnancy, shoulder dystocia, neonatal hyperbilirubinemia, and neonatal hypoglycemia (assessed within 48 hours of birth). RESULTS: A total of 962 women were randomized, and outcomes were available for 922. Of these 922 women, 459 (49.8%) were assigned to early screen and 463 (50.2%) to routine screen. Baseline characteristics were balanced between groups. In the early screening group, 69 (15.0%; 95% confidence interval, 11.9-18.6%) were diagnosed with gestational diabetes: 29 (6.3%; 95% confidence interval, 4.3-8.9%) at <20 weeks and 40 (8.7%; 95% confidence interval, 6.3-11.7%) at >24 weeks. Of those randomized to routine screening, 56 (12.1%; 95% confidence interval, 9.3-15.4%) had gestational diabetes. Early screening did not reduce the incidence of the primary outcome (56.9% in the early screen versus 50.8% in the routine screen, P = .07; relative risk, 1.12; 95% confidence interval, 0.99-1.26). CONCLUSION: Early screening for gestational diabetes in obese women did not reduce the composite perinatal outcome.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Harper LM, Jauk V, Longo S, et al. Early gestational diabetes screening in obese women: a randomized controlled trial. Am J Obstet Gynecol. 2020. PMID: 31926951. doi:10.1016/j.ajog.2019.12.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。